| Code | 9337D | ||||||||||
| MA number | EU/1/21/1593/005 | ||||||||||
| Product Form: | tbl flm 91x50 mg (blis.PVDC/Al) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Pfizer Europe MA EEIG, Belgium | ||||||||||
| Therapeutic Class: | 46 - DERMATOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 09.12.2021 |
| Validity: | 09.12.2026 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
CIBINQO_Príručka pre lekára_verzia 3_2024.pdf
|
| Dokument: |
CIBINQO_Karta pacienta_verzia 3_2024.pdf
|
| Safety feature | Yes |
| Data update: | 27.08.2024 |
